237 related articles for article (PubMed ID: 33216167)
1. Nicotinic receptor modulation of the default mode network.
Hahn B; Harvey AN; Concheiro-Guisan M; Huestis MA; Ross TJ; Stein EA
Psychopharmacology (Berl); 2021 Feb; 238(2):589-597. PubMed ID: 33216167
[TBL] [Abstract][Full Text] [Related]
2. Modafinil modulation of the default mode network.
Minzenberg MJ; Yoon JH; Carter CS
Psychopharmacology (Berl); 2011 May; 215(1):23-31. PubMed ID: 21153806
[TBL] [Abstract][Full Text] [Related]
3. Neurobiological impact of nicotinic acetylcholine receptor agonists: an activation likelihood estimation meta-analysis of pharmacologic neuroimaging studies.
Sutherland MT; Ray KL; Riedel MC; Yanes JA; Stein EA; Laird AR
Biol Psychiatry; 2015 Nov; 78(10):711-20. PubMed ID: 25662104
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.
Howe WM; Ji J; Parikh V; Williams S; Mocaër E; Trocmé-Thibierge C; Sarter M
Neuropsychopharmacology; 2010 May; 35(6):1391-401. PubMed ID: 20147893
[TBL] [Abstract][Full Text] [Related]
5. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
[TBL] [Abstract][Full Text] [Related]
6. An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds.
Simpraga S; Mansvelder HD; Groeneveld GJ; Prins S; Hart EP; Poil SS; Linkenkaer-Hansen K
Clin Neurophysiol; 2018 Nov; 129(11):2325-2332. PubMed ID: 30248622
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.
Roh S; Hoeppner SS; Schoenfeld D; Fullerton CA; Stoeckel LE; Evins AE
Psychopharmacology (Berl); 2014 Feb; 231(4):765-75. PubMed ID: 24114425
[TBL] [Abstract][Full Text] [Related]
8. Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex.
Parikh V; Man K; Decker MW; Sarter M
J Neurosci; 2008 Apr; 28(14):3769-80. PubMed ID: 18385335
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
Tani Y; Saito K; Imoto M; Ohno T
Eur J Pharmacol; 1998 Jun; 351(2):181-8. PubMed ID: 9687001
[TBL] [Abstract][Full Text] [Related]
10. Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.
Alvarez-Jimenez R; Hart EP; Prins S; de Kam M; van Gerven JMA; Cohen AF; Groeneveld GJ
Br J Clin Pharmacol; 2018 May; 84(5):888-899. PubMed ID: 29319910
[TBL] [Abstract][Full Text] [Related]
11. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
12. Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons.
Maloku E; Kadriu B; Zhubi A; Dong E; Pibiri F; Satta R; Guidotti A
Neuropsychopharmacology; 2011 Jun; 36(7):1366-74. PubMed ID: 21368748
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission.
Gioanni Y; Rougeot C; Clarke PB; Lepousé C; Thierry AM; Vidal C
Eur J Neurosci; 1999 Jan; 11(1):18-30. PubMed ID: 9987008
[TBL] [Abstract][Full Text] [Related]
14. Strain dependency of the effects of nicotine and mecamylamine in a rat model of attention.
Hahn B; Riegger KE; Elmer GI
Psychopharmacology (Berl); 2016 Apr; 233(8):1427-34. PubMed ID: 26875755
[TBL] [Abstract][Full Text] [Related]
15. Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder.
Ueno K; Togashi H; Matsumoto M; Ohashi S; Saito H; Yoshioka M
J Pharmacol Exp Ther; 2002 Jul; 302(1):95-100. PubMed ID: 12065705
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity.
Potter AS; Bucci DJ; Newhouse PA
Psychopharmacology (Berl); 2012 Mar; 220(2):331-40. PubMed ID: 21969123
[TBL] [Abstract][Full Text] [Related]
17. Unexpected loss of sensitivity to the nicotinic acetylcholine receptor antagonist activity of mecamylamine and dihydro-β-erythroidine in nicotine-tolerant mice.
de Moura FB; Wilkerson JL; McMahon LR
Brain Behav; 2020 Apr; 10(4):e01581. PubMed ID: 32092237
[TBL] [Abstract][Full Text] [Related]
18. Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects.
Hahn B; Shrieves ME; Olmstead CK; Yuille MB; Chiappelli JJ; Pereira EFR; Albuquerque EX; Fawcett WP
Psychopharmacology (Berl); 2020 Jan; 237(1):219-230. PubMed ID: 31686175
[TBL] [Abstract][Full Text] [Related]
19. An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
Baakman AC; Alvarez-Jimenez R; Rissmann R; Klaassen ES; Stevens J; Goulooze SC; den Burger JCG; Swart EL; van Gerven JMA; Groeneveld GJ
Br J Clin Pharmacol; 2017 Aug; 83(8):1676-1687. PubMed ID: 28217868
[TBL] [Abstract][Full Text] [Related]
20. Brain nicotinic acetylcholine receptors are involved in stress-induced potentiation of nicotine reward in rats.
Javadi P; Rezayof A; Sardari M; Ghasemzadeh Z
J Psychopharmacol; 2017 Jul; 31(7):945-955. PubMed ID: 28541827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
